Plain-English translation of NCT06552611 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Multiple Sclerosis research guide →Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This pilot study is testing a new approach called transcutaneous spinal cord stimulation — a non-invasive electrical treatment applied through electrodes on your skin over the spinal cord — combined with occupational hand therapy. The goal is to see whether this combination treatment can help restore arm and hand function in people with multiple sclerosis, especially when everyday treatments haven't fully addressed these problems.
While current MS medications can slow disease progression, they don't help people recover function they've already lost in their arms and hands. This trial explores whether electrical stimulation might help repair damage and improve movement and sensation in ways that therapy alone cannot.
You likely qualify if…
You likely don't qualify if…
You will complete two separate six-week treatment blocks, each separated by a six-week break. In one block, you'll receive hand therapy three times per week for one hour at a time. In the other block, you'll receive the same therapy but also wear electrodes on your skin that deliver gentle electrical stimulation to your spinal cord during those same sessions. The order is random, so you won't know which comes first. Throughout the study, researchers will test your arm and hand function and ask about pain, muscle stiffness, and quality of life.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
United States